340 related articles for article (PubMed ID: 33914273)
1. Deciphering molecular mechanisms of metastasis: novel insights into targets and therapeutics.
Kalita B; Coumar MS
Cell Oncol (Dordr); 2021 Aug; 44(4):751-775. PubMed ID: 33914273
[TBL] [Abstract][Full Text] [Related]
2. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into tumour metastasis: tracing the dominant events.
Jin K; Li T; van Dam H; Zhou F; Zhang L
J Pathol; 2017 Apr; 241(5):567-577. PubMed ID: 28035672
[TBL] [Abstract][Full Text] [Related]
4. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA regulation of epithelial-mesenchymal transition in cancer metastasis.
Xu Q; Deng F; Qin Y; Zhao Z; Wu Z; Xing Z; Ji A; Wang QJ
Cell Death Dis; 2016 Jun; 7(6):e2254. PubMed ID: 27277676
[TBL] [Abstract][Full Text] [Related]
6. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.
Liu S; Dai W; Jin B; Jiang F; Huang H; Hou W; Lan J; Jin Y; Peng W; Pan J
Mol Cancer; 2024 Jun; 23(1):122. PubMed ID: 38844984
[TBL] [Abstract][Full Text] [Related]
7. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
Sundararajan V; Sarkar FH; Ramasamy TS
Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
[TBL] [Abstract][Full Text] [Related]
8. A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer.
Foroutan M; Cursons J; Hediyeh-Zadeh S; Thompson EW; Davis MJ
Mol Cancer Res; 2017 May; 15(5):619-631. PubMed ID: 28119430
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.
Liu W; Vivian CJ; Brinker AE; Hampton KR; Lianidou E; Welch DR
Cancer Microenviron; 2014 Dec; 7(3):117-31. PubMed ID: 24938990
[TBL] [Abstract][Full Text] [Related]
10. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
[TBL] [Abstract][Full Text] [Related]
11. The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity.
Cao MX; Jiang YP; Tang YL; Liang XH
Oncotarget; 2017 Feb; 8(7):12472-12483. PubMed ID: 27992370
[TBL] [Abstract][Full Text] [Related]
12. Epithelial, mesenchymal and hybrid epithelial/mesenchymal phenotypes and their clinical relevance in cancer metastasis.
Garg M
Expert Rev Mol Med; 2017 Mar; 19():e3. PubMed ID: 28322181
[TBL] [Abstract][Full Text] [Related]
13. Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms.
Liao TT; Yang MH
Cells; 2020 Mar; 9(3):. PubMed ID: 32143517
[TBL] [Abstract][Full Text] [Related]
14. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis.
Dhamija S; Diederichs S
Int J Cancer; 2016 Jul; 139(2):269-80. PubMed ID: 26875870
[TBL] [Abstract][Full Text] [Related]
15. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.
Schliekelman MJ; Gibbons DL; Faca VM; Creighton CJ; Rizvi ZH; Zhang Q; Wong CH; Wang H; Ungewiss C; Ahn YH; Shin DH; Kurie JM; Hanash SM
Cancer Res; 2011 Dec; 71(24):7670-82. PubMed ID: 21987723
[TBL] [Abstract][Full Text] [Related]
16. A novel gene expression signature for bone metastasis in breast carcinomas.
Savci-Heijink CD; Halfwerk H; Koster J; van de Vijver MJ
Breast Cancer Res Treat; 2016 Apr; 156(2):249-59. PubMed ID: 26965286
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
[TBL] [Abstract][Full Text] [Related]
18. The Role of Drebrin in Cancer Cell Invasion.
Dart AE; Gordon-Weeks PR
Adv Exp Med Biol; 2017; 1006():375-389. PubMed ID: 28865033
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
Celià-Terrassa T; Meca-Cortés O; Mateo F; Martínez de Paz A; Rubio N; Arnal-Estapé A; Ell BJ; Bermudo R; Díaz A; Guerra-Rebollo M; Lozano JJ; Estarás C; Ulloa C; Álvarez-Simón D; Milà J; Vilella R; Paciucci R; Martínez-Balbás M; de Herreros AG; Gomis RR; Kang Y; Blanco J; Fernández PL; Thomson TM
J Clin Invest; 2012 May; 122(5):1849-68. PubMed ID: 22505459
[TBL] [Abstract][Full Text] [Related]
20. Metastasis regulation by PPARD expression in cancer cells.
Zuo X; Xu W; Xu M; Tian R; Moussalli MJ; Mao F; Zheng X; Wang J; Morris JS; Gagea M; Eng C; Kopetz S; Maru DM; Rashid A; Broaddus R; Wei D; Hung MC; Sood AK; Shureiqi I
JCI Insight; 2017 Jan; 2(1):e91419. PubMed ID: 28097239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
